Tetracosactide
( DrugBank: Tetracosactide / KEGG DRUG: Cosyntropin, Tetracosactide acetate )
4 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 83 | Addison disease | 2 |
| 113 | Muscular dystrophy | 4 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 145 | West syndrome | 2 |
| 222 | Primary nephrotic syndrome | 1 |
83. Addison disease
Clinical trials : 21 / Drugs : 29 - (DrugBank : 9) / Drug target genes : 6 - Drug target pathways : 18
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
113. Muscular dystrophy
Clinical trials : 766 / Drugs : 477 - (DrugBank : 119) / Drug target genes : 80 - Drug target pathways : 178
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
145. West syndrome
Clinical trials : 49 / Drugs : 43 - (DrugBank : 16) / Drug target genes : 29 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
222. Primary nephrotic syndrome
Clinical trials : 382 / Drugs : 278 - (DrugBank : 98) / Drug target genes : 73 - Drug target pathways : 197
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|